Search
for
Sort by
Research 541–570 of 1000+
- Commonly used hair oils in the Black community: a narrative review in their use to treat androgenetic alopecia
- Effects of oral minoxidil on nails: a cross‐sectional analysis
- Shared decision-making in central centrifugal cicatricial alopecia
- The microbiome in patients with atopic dermatitis
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Integrin signalling regulates YAP/TAZ to control skin homeostasis
- BRAF Inhibitor Dabrafenib in Patients with Metastatic <i>BRAF</i>-Mutant Thyroid Cancer
- European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity
- Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak
- Budesonide for maintenance of remission in Crohn's disease
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts
- The use of cyclosporine in dermatology: Part I
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- New Antifungal Agents and New Formulations Against Dermatophytes
- Appropriateness of oral drugs for long-term treatment of lower urinary tract symptoms in older persons: results of a systematic literature review and international consensus validation process (LUTS-FORTA 2014)
- A Subset of TREM2+ Dermal Macrophages Secretes Oncostatin M to Maintain Hair Follicle Stem Cell Quiescence and Inhibit Hair Growth
- Health Care Utilization in the 6 Months Following SARS-CoV-2 Infection
- Adverse Effects Associated with Long-Term Administration of Azole Antifungal Agents
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata
- Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- JAK Inhibitors for Treatment of Alopecia Areata
- TREM2 macrophages induced by human lipids drive inflammation in acne lesions